CIK: 1068029 - Address: C/O Soligenix, Inc., 29 Emmons Drive, Suite B-10, Princeton, NJ 08540
19 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
P%ret21712-121384518
P%wins71575743836763

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
5/18/22 18:01
5/18/22
SNGXSoligenix, Inc.DEHealthDrugPharmaceutical PreparationsSchaber Christopher JNJDOCB,CEO,PP90.44330202990D
12/20/21 16:23
12/17/21
SNGXSoligenix, Inc.DEHealthDrugPharmaceutical PreparationsSchaber Christopher JNJDOCB,CEO,PP50.7399071170D
12/14/21 16:05
12/14/21
SNGXSoligenix, Inc.DEHealthDrugPharmaceutical PreparationsSchaber Christopher JNJDOCB,CEO,PP70.72690101963D
11/19/19 16:18
11/19/19
SNGXSoligenix, Inc.DEHealthDrugPharmaceutical PreparationsSchaber Christopher JNJDOCB,CEO,PP100.93000112553D
4/22/19 16:41
4/22/19
SNGXSoligenix, Inc.DEHealthDrugPharmaceutical PreparationsSchaber Christopher JNJDOCB,CEO,PP40.7154051342D
10/18/18 16:51
10/18/18
SNGXSoligenix, Inc.DEHealthDrugPharmaceutical PreparationsSchaber Christopher JNJDOCB,CEO,PP101.17093037D
8/22/18 17:00
8/22/18
SNGXSoligenix, Inc.DEHealthDrugPharmaceutical PreparationsSchaber Christopher JNJDOCB,CEO,PP51.42041429D
12/20/16 10:02
12/16/16
SNGXSoligenix, Inc.DEHealthDrugPharmaceutical PreparationsSchaber Christopher JNJDOCB,CEO,PP.d503.1601617025D-82-77-65-67-38-38-2062-30-6
12/23/15 06:02
12/22/15
SNGXSoligenix, Inc.DEHealthDrugPharmaceutical PreparationsSchaber Christopher JNJDOCB,CEO,PP131.290101386D-3123-5019193714045-9-6-19-32-44-80
7/1/15 07:16
7/1/15
SNGXSoligenix, Inc.DEHealthDrugPharmaceutical PreparationsSchaber Christopher JNJDOCB,CEO,PM.d40.610007983D1221012639514142-2-2-20-32-54-48-74
12/24/14 10:06
12/22/14
SNGXSoligenix, Inc.DEHealthDrugPharmaceutical PreparationsSchaber Christopher JNJDOCB,CEO,PP.d101.21081276D76-43-52-49-46-33-27-24-1-466313512
5/14/14 07:28
5/13/14
SNGXSoligenix, Inc.DEHealthDrugPharmaceutical PreparationsSchaber Christopher JNJDOCB,CEO,PM.d50.6400081367D44247-114-7-6210-3-84-2-10-25
6/26/13 16:18
6/25/13
SNGXSoligenix, Inc.DEHealthDrugPharmaceutical PreparationsSchaber Christopher JNJDOCB,CEO,PP.d101.050101960D-7622066-27-30-45-40-36604612083119
4/11/12 19:12
4/10/12
SNGXSoligenix, Inc.DEHealthDrugPharmaceutical PreparationsSchaber Christopher JNJDOCB CEO,PP50.50980102550D-91-88-40-20-23-9-4700-25-2329196
9/30/09 15:43
9/28/09
SNGXSoligenix, Inc.DEHealthDrugPharmaceutical PreparationsSchaber Christopher JNJDOCEOP.d200.253007920472D-2717014550294208415-26-70-30
8/29/07 12:51
8/28/07
DORBDor Biopharma IncDEHealthDrugPharmaceutical PreparationsSchaber Christopher JFLDOCEOP290.2906010034393D
2/13/07 07:56
2/9/07
DORBDor Biopharma IncDEHealthDrugPharmaceutical PreparationsSchaber Christopher JFLDOCEOP.d1000.47000213266293D
3/17/05 13:16
3/17/05
DSCODiscovery Laboratories Inc /de/DEHealthBioPrdBiological Products, (No DiagSchaber ChristopherPAOExec. VPP795.230157223D216-56-38-42-15-131081212292253
3/3/04 14:35
3/1/04
DSCODiscovery Laboratories Inc /de/DEHealthBioPrdBiological Products, (No DiagSchaber ChristopherPAOEVP,COOM.d2231.790125152207D6246644392836-1-10-36-55

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact